Form D — SISCAPA Assay Technologies, Inc.
0001528248-25-000005 · filed 2025-08-28
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $1,999,940
- Total sold
- $1,999,940
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- SISCAPA Assay Technologies, Inc.
- CIK
- 1528248
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1759 WILLARD ST NW
WASHINGTON, DC 20009 - Phone
- (301) 728-1451
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Norman Liegh Anderson · Executive OfficerWashington, DC Find on LinkedIn ↗
-
Constance L. Seniff · Executive OfficerWashington, DC Find on LinkedIn ↗
-
Terry W. Pearson · DirectorWashington, DC Find on LinkedIn ↗
-
Gus Salem · DirectorWashington, DC Find on LinkedIn ↗
View original on SEC EDGAR.